Ryman Healthcare Price to Free Cash Flow Ratio 2024-2024 | RYHTY

Ryman Healthcare price to free cash flow ratio from 2024 to 2024. Price to free cash flow ratio can be defined as

Ryman Healthcare Price to Free Cash Flow Ratio 2024-2024 | RYHTY

Ryman Healthcare price to free cash flow ratio from 2024 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$89.4B
Cencora (COR)$46.8B
DiDi Global (DIDIY)$22.8B
Natera (NTRA)$20.9B
ICON (ICLR)$16.3B
Avantor (AVTR)$15B
Revvity (RVTY)$14.4B
BioMerieux (BMXMF)$13.8B
Viatris (VTRS)$13.5B
Solventum (SOLV)$12.7B
CochLear (CHEOY)$12.3B
Medpace Holdings (MEDP)$10.5B
Doximity (DOCS)$10B
EUROFINS SCIENT (ERFSF)$9.6B
HealthEquity (HQY)$8.9B
Charles River Laboratories (CRL)$8.4B
Sonic Healthcare (SKHHY)$8.2B
Amplifon S.p.A (AMFPF)$6.1B
Bausch + Lomb (BLCO)$6.1B
Organon (OGN)$4.1B
Sotera Health (SHC)$3.7B
BrightSpring Health Services (BTSG)$3.2B
Alignment Healthcare (ALHC)$2.8B
Concentras Parent (CON)$2.7B
Surgery Partners (SGRY)$2.6B
Premier (PINC)$2.2B
PACS (PACS)$2.1B
Ardent Health Partners (ARDT)$2B
GeneDx Holdings (WGS)$1.9B
Progyny (PGNY)$1.8B